The U.S. COVID-19 public health emergency comes to an end on Thursday, but the fight against COVID goes on.
Vaccine requirements for federal workers and federal contractors, as well as foreign air travelers to the U.S., will end May 11.
The two companies have said they expect roughly 100 million Covid-19 vaccines doses to be administered in the U.S. this year.
Biotech and Pharma BioNTech Stock Is Falling. Blame the Covid Vaccine Outlook.
The German biotech that partnered with Pfizer to develop a Covid-19 vaccine expects fewer vaccinations and lowered levels of boosting this year.
It has been three years since the U.S. stock market hit its COVID-19 bottom as the global economy suddenly shut down at the onset of the pandemic in early 2020.
Moderna’s CEO is faces a Senate grilling over $130 Covid-19 shot, Google expands public access to its ‘Bard’ chatbot, and other news to start your day.
WHO panel is reviewing whether COVID vaccines need updating, as agency monitors 7 omicron subvariants
Most of the week's COVID news is focused on vaccines, including the big slide in Moderna's revenue caused by falling demand.
Moderna’s stock hit as flu-vaccine trial fails on one target. Meanwhile, China declares victory over COVID.
Moderna Inc.'s stock slid 5% Friday, after the COVID vaccine maker said a trial of a flu-vaccine candidate failed to meet one of its goals.
House Republicans have launched a probe into the origins of COVID by issuing a series of letters to current and former Biden administration officials.